Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Family Practice
|
January 6, 2001
Loyalty to the regular care provider: patients' and physicians' views
D Roberge, M D Beaulieu, S Haddad, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
November 10, 2010
Clinical significance of molecular biomarkers in glioblastoma
C Ang, M-C Guiot, A V Ramanakumar, et al.
Revue D'Epidemiologie Et De Sante Publique
|
December 7, 2006
[Development and application of a clinical vignette to assess the quality of cancer care]
L Cazale, D Tremblay, D Roberge, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
July 12, 2011
Inter- and intra-observer variation in soft-tissue sarcoma target definition
D Roberge, T Skamene, R E Turcotte, et al.
Clinical and Diagnostic Laboratory Immunology
|
November 1, 1995
Cloning of porcine cytokine-specific cDNAs and detection of porcine tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-1 beta gene expression by reverse transcription PCR and chemiluminescence hybridization
S A Vézina, D Roberge, M Fournier, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
September 25, 1999
Practice guidelines for clinical prevention: do patients, physicians and experts share common ground?
M D Beaulieu, E Hudon, D Roberge, et al.
The British Journal of Dermatology
|
January 4, 2007
Does adjuvant alpha-interferon improve outcome when combined with total skin irradiation for mycosis fungoides?
D Roberge, T Muanza, G Blake, et al.
Medical Physics
|
May 19, 2017
Poster - Thur Eve - 73: Prediction of risks of cardiac mortality and secondary cancers after radiotherapy for Hodgkin's lymphoma, non-Hodgkin's lymphoma, and breast cancer
A Toltz, N Shin, C Laude, et al.
Current Oncology (Toronto, Ont.)
|
December 17, 2008
Fractionated stereotactic radiotherapy in the treatment of pituitary macroadenomas
H Elhateer, T Muanza, D Roberge, et al.
Current Oncology (Toronto, Ont.)
|
April 20, 2012
What is the optimal management of dysphagia in metastatic esophageal cancer?
W C Hanna, M Sudarshan, D Roberge, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Family Practice
|
January 6, 2001
Loyalty to the regular care provider: patients' and physicians' views
D Roberge, M D Beaulieu, S Haddad, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
November 10, 2010
Clinical significance of molecular biomarkers in glioblastoma
C Ang, M-C Guiot, A V Ramanakumar, et al.
Revue D'Epidemiologie Et De Sante Publique
|
December 7, 2006
[Development and application of a clinical vignette to assess the quality of cancer care]
L Cazale, D Tremblay, D Roberge, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
July 12, 2011
Inter- and intra-observer variation in soft-tissue sarcoma target definition
D Roberge, T Skamene, R E Turcotte, et al.
Clinical and Diagnostic Laboratory Immunology
|
November 1, 1995
Cloning of porcine cytokine-specific cDNAs and detection of porcine tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-1 beta gene expression by reverse transcription PCR and chemiluminescence hybridization
S A Vézina, D Roberge, M Fournier, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
September 25, 1999
Practice guidelines for clinical prevention: do patients, physicians and experts share common ground?
M D Beaulieu, E Hudon, D Roberge, et al.
The British Journal of Dermatology
|
January 4, 2007
Does adjuvant alpha-interferon improve outcome when combined with total skin irradiation for mycosis fungoides?
D Roberge, T Muanza, G Blake, et al.
Medical Physics
|
May 19, 2017
Poster - Thur Eve - 73: Prediction of risks of cardiac mortality and secondary cancers after radiotherapy for Hodgkin's lymphoma, non-Hodgkin's lymphoma, and breast cancer
A Toltz, N Shin, C Laude, et al.
Current Oncology (Toronto, Ont.)
|
December 17, 2008
Fractionated stereotactic radiotherapy in the treatment of pituitary macroadenomas
H Elhateer, T Muanza, D Roberge, et al.
Current Oncology (Toronto, Ont.)
|
April 20, 2012
What is the optimal management of dysphagia in metastatic esophageal cancer?
W C Hanna, M Sudarshan, D Roberge, et al.
Page
of 4